why am i gaining weight on retatrutide 30 Days of — LessWrong A Clinician's Guide to Retatrutide
Description
hsCRP (High-Sensitivity C-Reactive Protein) Inflammatory burden is an important driver of metabolic disease and cardiovascular risk
Could this be the ultimate solution for obesity and diabetes
GLP-1 medications slow gastric emptying by design, that's part of how they reduce appetite and improve postprandial glucose control
Some patients have a strong aversion to injections, while others prefer the simplicity of a once-weekly dose
That glucose-dependent mechanism is the key distinction
Is this enough to start using finerenone in DKD due to type 1 diabetes - taken together with the T2D data from FIDELITY
